These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 32173438)
1. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies. Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438 [TBL] [Abstract][Full Text] [Related]
2. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations. Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study. Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854 [TBL] [Abstract][Full Text] [Related]
4. Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690 [TBL] [Abstract][Full Text] [Related]
5. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of alpha amylase inhibitors based on privileged indole scaffold. Noreen T; Taha M; Imran S; Chigurupati S; Rahim F; Selvaraj M; Ismail NH; Mohammad JI; Ullah H; Javid MT; Nawaz F; Irshad M; Ali M Bioorg Chem; 2017 Jun; 72():248-255. PubMed ID: 28482265 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors. Seyfi S; Salarinejad S; Moghimi S; Toolabi M; Sadeghian N; Tüzün B; Firoozpour L; Ketabforoosh SHME; Taslimi P; Foroumadi A Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300628. PubMed ID: 38501879 [TBL] [Abstract][Full Text] [Related]
8. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation. Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516 [TBL] [Abstract][Full Text] [Related]
9. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies. Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies. Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, α-amylase inhibitory potential and molecular docking study of indole derivatives. Taha M; Baharudin MS; Ismail NH; Imran S; Khan MN; Rahim F; Selvaraj M; Chigurupati S; Nawaz M; Qureshi F; Vijayabalan S Bioorg Chem; 2018 Oct; 80():36-42. PubMed ID: 29864686 [TBL] [Abstract][Full Text] [Related]
12. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics. Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies. Rafique R; Khan KM; Arshia ; Kanwal ; Chigurupati S; Wadood A; Rehman AU; Karunanidhi A; Hameed S; Taha M; Al-Rashida M Bioorg Chem; 2020 Jan; 94():103195. PubMed ID: 31451297 [TBL] [Abstract][Full Text] [Related]
14. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation. Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus. Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study. Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383 [TBL] [Abstract][Full Text] [Related]
17. Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors. Saleem F; Shamim F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Solangi M; Khan KM Future Med Chem; 2023 Aug; 15(15):1343-1368. PubMed ID: 37650736 [No Abstract] [Full Text] [Related]
18. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies. Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061 [TBL] [Abstract][Full Text] [Related]
19. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies. Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors. Aispuro-Pérez A; López-Ávalos J; García-Páez F; Montes-Avila J; Picos-Corrales LA; Ochoa-Terán A; Bastidas P; Montaño S; Calderón-Zamora L; Osuna-Martínez U; Sarmiento-Sánchez JI Bioorg Chem; 2020 Jan; 94():103491. PubMed ID: 31818480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]